How to Get Rid of Nasal Polyps Without Surgery

Nasal polyps can often be shrunk or controlled without an operating room, though the right approach depends on how severe your polyps are, what is driving the inflammation, and how your body responds to treatment. Corticosteroid sprays and rinses are the usual starting point, but a growing menu of options now includes biologic injections, steroid-releasing implants placed in the office, aspirin desensitization, and targeted dietary changes. The key is understanding which tools match your situation and recognizing when non-surgical management has reached its limits.

Corticosteroid Sprays, Drops, and Irrigations

Topical corticosteroids are the foundation of non-surgical polyp treatment. Standard nasal steroid sprays, like fluticasone or mometasone, deliver anti-inflammatory medication directly to the lining of the nose. For many people with mild polyps, daily use over weeks to months gradually reduces polyp size, opens blocked passages, and eases congestion. The effect is not dramatic overnight, but consistent use makes a measurable difference in both symptoms and polyp grade over time.

One limitation of standard sprays is reach. Polyps tend to originate high in the sinuses and around the narrow openings that connect the sinuses to the nasal cavity. A simple squeeze-bottle spray may not get medication to those areas effectively. Newer delivery systems try to solve this problem. An exhalation delivery system designed to push fluticasone deeper into the nasal passages showed significant reductions in both nasal congestion and polyp grade compared to placebo across multiple trials, with improvement sustained out to 24 weeks.¹ A meta-analysis of the clinical data on this system confirmed its effectiveness at two different dose levels.²

High-volume steroid irrigations, where you dissolve budesonide in a large-volume saline rinse and flush it through the sinuses, are another way to improve drug delivery. A study comparing budesonide irrigations against plain saline irrigations found that the steroid rinse produced significantly greater improvements in both symptom scores and endoscopic appearance.³ A randomized trial directly comparing corticosteroid irrigations to standard nasal steroid sprays found the irrigations outperformed sprays for polyp size reduction over 12 weeks.⁴ If your doctor has you on a standard spray and it’s not doing enough, switching to a high-volume rinse with dissolved budesonide is a common next step before considering anything more aggressive.

Short Courses of Oral Steroids

When polyps are large enough to cause significant blockage or smell loss, doctors sometimes prescribe a short burst of oral prednisone or prednisolone, typically lasting one to two weeks. The effect can be rapid. In one randomized trial, patients who took oral prednisolone for two weeks saw a mean decrease in polyp grade of about 2 units, compared to essentially no change in the placebo group.⁵ Another study confirmed that two weeks of oral prednisolone produced significantly greater improvements in all nasal symptoms, airflow, and polyp size compared to placebo.⁶

The catch is that the gains from oral steroids tend to fade once you stop taking them. That is why the standard strategy is to use a short oral burst to knock polyps back, then immediately step down to topical steroids to maintain the improvement. Oral steroids also come with side effects that make repeated courses risky: temporary suppression of your adrenal glands, increased bone turnover, blood sugar spikes, mood changes, and weight gain. Most doctors limit patients to two or three short courses per year at most. If you find yourself needing oral steroids more often than that to keep polyps in check, it is a sign that your disease may need a different approach entirely.

Biologic Medications

Biologics represent the biggest shift in polyp treatment in decades. These are injectable medications, given under the skin every two to four weeks, that block specific molecules fueling the inflammation behind polyps. Three have strong evidence for nasal polyps: dupilumab (which blocks interleukin-4 and interleukin-13), omalizumab (which binds IgE), and mepolizumab (which targets interleukin-5). All three address the type 2 inflammation that drives most cases of chronic rhinosinusitis with nasal polyps.⁷

A systematic review of randomized trials evaluating all three biologics found that dupilumab produced the strongest across-the-board results. It reduced the need for surgery or oral steroid rescue by roughly 70%, with meaningful improvements in sense of smell and quality of life.⁸ Omalizumab also significantly cut the need for surgery and improved smell, congestion, and quality of life, with benefits seen regardless of whether the patient had underlying allergies.⁹ Subgroup analyses of omalizumab showed consistent benefits in patients with high eosinophil counts, prior sinus surgery, coexisting asthma, and aspirin sensitivity.¹⁰ Mepolizumab showed more modest results, with lower certainty evidence for its effects on quality of life and smell.⁸

One practical reality of biologics is that they need to be continued. An open-label extension study of omalizumab showed that patients who stayed on the drug continued improving through a full year, but after stopping, their scores gradually worsened over the next six months, though they did remain better than their pre-treatment baseline.¹¹ Biologics are also expensive and usually reserved for people whose polyps keep coming back despite steroids and, in many guidelines, despite at least one prior surgery. Real-world data comparing dupilumab and mepolizumab head-to-head are still limited, though early comparisons suggest dupilumab may have a broader effect.¹²

In-Office Steroid-Eluting Implants

Steroid-eluting sinus implants sit in an interesting gray zone between medication and procedure. They are small, bioabsorbable devices placed directly into the sinus cavity during an office visit, usually in patients who have had prior sinus surgery and have polyps growing back. The implant slowly releases a corticosteroid (typically mometasone) over weeks, delivering a high local dose right where the polyps are without the systemic side effects of oral steroids.

A prospective multicenter study found that within one month of placement, the mean bilateral polyp grade dropped from about 4.5 to 2.3, and that improvement held through six months.¹³ The RESOLVE trial, a randomized controlled study, confirmed that patients receiving the implant experienced significant reductions in both polyp grade and sinus obstruction at three months compared to a sham procedure group.¹⁴ No serious adverse events were reported in either study. The implant is typically placed under local anesthesia and takes a few minutes. Whether you consider this “surgery” is partly semantic, but it avoids general anesthesia, an operating room, and the tissue removal involved in traditional endoscopic sinus surgery.

Aspirin Desensitization for AERD

A specific subset of polyp patients has a condition called aspirin-exacerbated respiratory disease, or AERD, sometimes known as Samter’s triad. These individuals have nasal polyps, asthma, and respiratory reactions to aspirin and other common painkillers. Their polyps tend to be aggressive, fast-growing, and resistant to standard treatment. If this profile fits you, aspirin desensitization is worth discussing with your allergist.

The process involves gradually increasing doses of aspirin under medical supervision until you can tolerate a full therapeutic dose, then staying on daily aspirin indefinitely. An American Academy of Allergy, Asthma and Immunology work group report noted that while AERD patients traditionally develop significant upper and lower airway symptoms when they take aspirin, most of those same patients experience clinical benefit when desensitized and maintained on daily therapy.¹⁵ A clinical study found that desensitized patients showed improved quality of life, reduced symptoms, lower medication needs, decreased levels of the inflammatory marker IL-5, and improved lung function.¹⁶ The desensitization itself carries risk and must be done in a supervised medical setting, but for the right patient it can meaningfully slow polyp regrowth and reduce the cycle of repeated surgeries.

Dietary Changes for Aspirin-Sensitive Patients

For AERD patients specifically, a low-salicylate diet has shown promise as an add-on strategy. Salicylates are compounds found naturally in many fruits, vegetables, spices, and processed foods. They are chemically related to aspirin, and some researchers believe that reducing dietary salicylate intake can lower the overall inflammatory burden in people sensitive to these compounds.

A multicenter randomized crossover trial found that AERD patients following a low-salicylate diet had statistically significant improvements in sinus symptom scores, nasal symptom severity, asthma control, endoscopic polyp appearance, and overall Lund-Kennedy endoscopy scores compared to their own results on a regular diet.¹⁷ A smaller follow-up crossover trial confirmed that patients on the low-salicylate diet reported improved symptom scores, particularly in the areas of sinus symptoms, ear and facial discomfort, and sleep quality.¹⁸ A more recent study found that the benefit was most pronounced in patients who had immediate-type reactions to aspirin, suggesting the diet works best for a particular subgroup within AERD.¹⁹

This is not a cure and not relevant for all polyp patients. If you do not have AERD, cutting salicylates out of your diet is unlikely to help your polyps. But for the right patient, it can be a meaningful piece of a broader management plan, especially alongside aspirin desensitization or biologic therapy.

Saline and Xylitol Nasal Irrigations

Regular saline nasal irrigation, using a neti pot or squeeze bottle, is one of the simplest and safest things you can do for nasal polyps. It physically washes out mucus, allergens, bacteria, and inflammatory debris from the nasal passages. On its own, saline will not shrink polyps the way steroids do, but it improves comfort, supports the effectiveness of other treatments, and helps keep the sinuses healthier overall.

Some evidence suggests that adding xylitol, a sugar alcohol, to nasal irrigations may offer a slight edge over plain saline. In a study of post-surgical patients, the xylitol irrigation group showed larger symptom improvements than the saline-only group across multiple measures.²⁰ Xylitol appears to have mild antibacterial properties and may help thin mucus. The effect is modest, and xylitol rinses are not widely adopted in clinical practice yet, but they are inexpensive and well tolerated if you want to try them.

Reducing Environmental Triggers

Managing the environment around you will not shrink existing polyps, but it can slow the cycle of inflammation that feeds them. Research has established that air pollutants, tobacco smoke, occupational chemical exposures, and even microplastics can damage the lining of the sinuses and promote the type of inflammation that sustains polyps.²¹ A review of multiple studies found that smoke exposure was the most commonly linked environmental factor in chronic sinusitis, followed by farming and pesticide exposure.²² Another study found that the odds of having polyps were dramatically higher in people with certain environmental and occupational chemical exposures.²³

Practical steps include quitting smoking, using appropriate respiratory protection if you work around chemicals or dust, running a HEPA air purifier at home, and managing indoor allergens like dust mites and mold. If you have confirmed allergies, treating the allergy itself may reduce the inflammatory load on your sinuses. Allergen-specific immunotherapy (allergy shots or sublingual drops) has been studied as an add-on for sinusitis, though a systematic review found only weak evidence to support its use specifically for chronic rhinosinusitis beyond treating the underlying allergic rhinitis.²⁴ In the specific case of allergic fungal sinusitis, sublingual immunotherapy showed promise in a small study, with decreases in symptoms, imaging scores, and IgE levels.²⁵

Getting Your Sense of Smell Back

Loss of smell is often the symptom that bothers polyp patients the most, and it can be one of the slowest to improve. Polyps physically block odor molecules from reaching the smell receptors high in the nose, and the chronic inflammation itself can damage those receptors over time. Encouragingly, medical treatment can restore smell function in many cases.

A meta-analysis of olfactory outcomes found that oral steroids produced significant improvement in both subjective and objective smell testing compared to placebo, while topical steroids and combination therapy also improved subjective smell scores.²⁶ A study that tracked patients through a course of oral steroids followed by nasal steroids confirmed significant improvement in smell detection and identification as early as two weeks, with the gains holding at 12 weeks of continued topical treatment.²⁷

For people whose smell does not recover sufficiently with steroids alone, biologic therapies have shown strong effects on olfaction. In the systematic review of biologic trials, dupilumab produced the largest improvement in smell test scores, while omalizumab also showed significant gains.⁸ Clinical guidelines now recommend biologics for certain patients with uncontrolled polyps in part because of their ability to restore smell, a quality-of-life improvement that traditional surgery does not always deliver reliably, since smell loss can recur after surgical polyp removal.²⁸

When Non-Surgical Approaches Are Not Enough

All the options above work along a continuum, and not every patient will achieve adequate control without surgery. Several factors predict more stubborn disease: smoking, coexisting asthma, confirmed allergies, a deviated septum, and a history of prior sinus surgery all increase the likelihood that polyps will recur or resist medical management.²⁹ The underlying biology matters too. Polyps driven by heavy eosinophilic infiltration and high local IgE levels, especially when paired with asthma, tend to be more aggressive and harder to keep at bay with topical treatments alone.³⁰

It is also important to be sure that what you are treating is actually a benign nasal polyp. Not every growth in the nose is a polyp. Inverted papillomas, for example, are benign tumors that can look like polyps on examination but require surgical removal because they carry a risk of malignant transformation. A diagnostic meta-analysis found that serum squamous cell carcinoma antigen levels can help distinguish inverted papillomas from ordinary polyps.³¹ If a polyp is one-sided, bleeding, or not responding to steroids the way you would expect, your doctor should investigate further before assuming it is a routine polyp that can be managed medically.

Nasal Polyps in Children

Nasal polyps are uncommon in children, and when they appear before puberty, the first concern is cystic fibrosis. In one study following children with CF, over half developed at least one episode of nasal polyposis during three years of monitoring, with the youngest diagnosis at about two and a half years old. Most of these polyps were low-grade and treated with topical nasal corticosteroids, and roughly 57% responded to medical therapy at the next follow-up evaluation. Only one patient with severe bilateral polyps ultimately needed surgery.³² Treatment options for CF-related polyps mirror those for adults, with saline irrigations, nasal steroid sprays, and occasionally short oral steroid courses as the standard conservative steps.³³ Biologics are increasingly being studied in younger patients, though data on their use for nasal polyps in children remain limited.

Quercetin and Other Supplements

You will find plenty of claims online about natural supplements for nasal polyps. The one with the most emerging laboratory data is quercetin, a plant-derived compound found in onions, apples, berries, and green tea. In mouse models of chronic rhinosinusitis, quercetin reduced nasal mucosal inflammation, decreased levels of several pro-inflammatory markers, and protected the nasal lining from damage in a dose-dependent fashion.³⁴ A separate animal study specifically looking at polyp formation found that quercetin reduced polyp development and nasal mucosal remodeling in mice.³⁵

The honest caveat is that these are animal studies. A compound that reduces inflammation in a mouse nose does not automatically do the same in a human. No randomized controlled trial has demonstrated that quercetin supplements shrink nasal polyps in people. Taking quercetin as a supplement is generally considered safe at typical doses, and it is unlikely to cause harm, but it should not replace proven treatments. If you want to try it, think of it as a possible adjunct alongside your steroid spray and saline rinses, not as a substitute for them. The gap between promising animal data and confirmed clinical benefit is large, and plenty of compounds that looked encouraging in mice have gone on to disappoint in human trials.